Key result
Bilateral cardiac sympathetic denervation achieved complete resolution of ventricular arrhythmias in 100% of patients with refractory electrical storm, with no complications or mortalities.
Why the study?
Cardiac sympathetic denervation serves as a last-resort option for pharmacologically refractory ventricular arrhythmias, prompting the authors to report their clinical experience with bilateral denervation.
Does bilateral cardiac sympathetic denervation improve outcomes in patients with refractory ventricular arrhythmias?
Observational (n=6)
No
Does bilateral cardiac sympathetic denervation improve outcomes in patients with refractory ventricular arrhythmias?
Bilateral cardiac sympathetic denervation appears to be an effective and safe last-line option for treating refractory ventricular arrhythmias, achieving complete resolution in a small case series.
May support use in refractory electrical storm; leaves open confirmation in prospective trials.
Left or bilateral cardiac sympathetic denervation is employed as a final option for treating pharmacologically refractory ventricular arrhythmias of various etiologies. In this study, we share our experience with bilateral cardiac denervation. A total of 6 patients (mean age 73.8 years ± 6.5 years, mean LVEF 37 ± 8.3%), between 2021 and 2022, with sarcoidosis or ischemic heart disease underwent bilateral cardiac denervation due to electrical storm despite prior treatments. It was achieved complete resolution of ventricular arrhythmias in 100% of cases, with no recurrence of cardiac device shocks and no mortalities, neither cases of pneumothorax, Horner's syndrome, or other complications. Therefore, it was concluded that in this study, bilateral cardiac denervation was effective for treatment of refractory ventricular arrhythmias. Further larger studies are required to confirm these findings. La simpatectomía cardiaca izquierda o bilateral es usada como opción de última línea en el tratamiento de arritmias ventriculares refractarias de diferentes etiologías. En el siguiente texto, presentamos nuestra experiencia con la denervación cardiaca bilateral. En total, seis pacientes (edad promedio 73,8 ± 6,5, fracción de eyección del ventrículo izquierdo (FEVI) promedio 37 ± 8,3%) entre los años 2021 y 2022, con enfermedad cardiaca isquémica o sarcoidosis, fueron llevados a simpatectomía cardiaca bilateral por tormenta arrítmica que fue refractaria a otros tratamientos. Se consiguió una resolución completa de las arritmias ventriculares en 100% de los casos, sin recurrencias de descargas de los dispositivos cardiacos implantables y sin mortalidades reportadas. Tampoco se observaron situaciones de neumotórax, síndrome de Horner u otras complicaciones. Por lo anterior, pudimos concluir que, en este estudio, la simpatectomía cardiaca bilateral fue efectiva y segura para el tratamiento de las arritmias ventriculares refractarias. Se requieren estudios más grandes y comparativos para confirmar los hallazgos.
No takes yet. Share an insight, caveat, or question.
Arredondo-Mora et al. (2024) conducted an observational in Refractory ventricular arrhythmias / electrical storm (n=6). Bilateral cardiac sympathetic denervation was evaluated on Complete resolution of ventricular arrhythmias. Bilateral cardiac sympathetic denervation achieved complete resolution of ventricular arrhythmias in 100% of patients with refractory electrical storm, with no complications or mortalities.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: